MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MLTX
  4. News
MLTX
Quote
Short
News
Articles
Message Board

MoonLake Immunotherapeutics (NASDAQ : MLTX ) News

MoonLake Immunotherapeutics (NASDAQ: MLTX) News Releases

MLTX News Releases
MLTX : NASDAQ
US Earnings Reports
Expected US Company Earnings on Wednesday, February 25th, 2026
MLTX : NASDAQ
US Earnings Reports
Expected earnings - MoonLake Immunotherapeutics
MLTX : NASDAQ
SeekingAlpha
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal
MLTX : NASDAQ
KlickAnalytics
MLTX Price Target Alert: $35.00. Issued by Oppenheimer
MLTX : NASDAQ
SeekingAlpha
Invesco QQQ Income Advantage ETF declares monthly distribution of $0.4511
MLTX : NASDAQ
SeekingAlpha
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MLTX : NASDAQ
GlobeNewswire
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
MLTX : NASDAQ
GlobeNewswire
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
MLTX : NASDAQ
SeekingAlpha
MoonLake nabs FDA Fast Track status for rare inflammatory disorder asset
MLTX : NASDAQ
GlobeNewswire
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.